Search - tctmd.com

Displaying 681 - 700 of 872

Sort: Relevancy | Date

News Daily News

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Caitlin E. Cox

June 28, 2013

News Daily News

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Caitlin E. Cox

June 20, 2013

Presentation TVT 2013

Progressive Transvalvular Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Presenter: Fernando Javier Pineda A

June 13, 2013

Presentation TVT 2013

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR: A Recent Meta-Analysis

Presenter: Samir Kapadia

June 13, 2013

Presentation TVT 2013

Cardiogenic Shock due to Severe Ischemic Mitral Regurgitation: MitraClip Therapy as a Bridge to Surgical Intervention

Presenter: Anita Asgar

June 13, 2013

Presentation TVT 2013

Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve

Presenter: Petra Poliacikova

June 12, 2013

Presentation TVT 2013

An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease

Presenter: Peter Pollak

June 12, 2013

News Daily News

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

June 07, 2013

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Daily News

Dimensionamiento del ánulo basado en la TC reduce la regurgitación después de una TAVR

Yael L. Maxwell

May 29, 2013

News Daily News

CT-Based Annulus Sizing Reduces Regurgitation After TAVR

Yael L. Maxwell

May 29, 2013

News Industry News

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

May 23, 2013

News Industry News

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

May 22, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Daily News

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Caitlin E. Cox

May 17, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

May 17, 2013

News Industry News

Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System

May 16, 2013

Advertisement

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Progressive Transvalvular Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR: A Recent Meta-Analysis

Cardiogenic Shock due to Severe Ischemic Mitral Regurgitation: MitraClip Therapy as a Bridge to Surgical Intervention

Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve

An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Tumor Marker Predicts TAVR Outcomes

Dimensionamiento del ánulo basado en la TC reduce la regurgitación después de una TAVR

CT-Based Annulus Sizing Reduces Regurgitation After TAVR

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content